Truist Financial Corp Has $113.44 Million Stake in MetLife, Inc. (NYSE:MET)

Truist Financial Corp lowered its position in MetLife, Inc. (NYSE:MET - Free Report) by 11.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,715,392 shares of the financial services provider's stock after selling 220,911 shares during the quarter. Truist Financial Corp owned 0.23% of MetLife worth $113,439,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in MET. Criterion Capital Advisors LLC purchased a new stake in MetLife during the 4th quarter worth about $26,000. Quintet Private Bank Europe S.A. acquired a new stake in MetLife in the 3rd quarter worth about $28,000. Planned Solutions Inc. acquired a new stake in MetLife in the 4th quarter worth about $28,000. Tennessee Valley Asset Management Partners acquired a new stake in MetLife in the 4th quarter worth about $34,000. Finally, Headlands Technologies LLC acquired a new stake in MetLife in the 3rd quarter worth about $36,000. Hedge funds and other institutional investors own 89.81% of the company's stock.

MetLife Stock Down 2.1 %

MetLife stock traded down $1.48 during midday trading on Friday, hitting $70.42. 5,650,572 shares of the company were exchanged, compared to its average volume of 2,506,510. The company's fifty day moving average price is $71.44 and its 200-day moving average price is $67.19. The company has a market cap of $50.92 billion, a PE ratio of 38.48, a price-to-earnings-growth ratio of 0.54 and a beta of 1.04. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a fifty-two week low of $48.95 and a fifty-two week high of $74.68.


MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings data on Wednesday, January 31st. The financial services provider reported $1.93 EPS for the quarter, missing analysts' consensus estimates of $1.95 by ($0.02). The company had revenue of $18.72 billion for the quarter, compared to the consensus estimate of $18.07 billion. MetLife had a return on equity of 19.48% and a net margin of 2.36%. On average, research analysts predict that MetLife, Inc. will post 8.71 EPS for the current fiscal year.

MetLife Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 11th. Investors of record on Tuesday, May 7th will be paid a dividend of $0.545 per share. This is an increase from MetLife's previous quarterly dividend of $0.52. This represents a $2.18 dividend on an annualized basis and a yield of 3.10%. The ex-dividend date is Monday, May 6th. MetLife's dividend payout ratio is presently 113.66%.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. The Goldman Sachs Group raised MetLife from a "neutral" rating to a "buy" rating and raised their price target for the stock from $70.00 to $80.00 in a research note on Monday, January 8th. UBS Group reduced their price objective on MetLife from $87.00 to $82.00 and set a "buy" rating on the stock in a research note on Monday, February 5th. Piper Sandler lifted their price objective on MetLife from $74.00 to $85.00 and gave the company an "overweight" rating in a research note on Friday, April 5th. Keefe, Bruyette & Woods lifted their price objective on MetLife from $82.00 to $87.00 and gave the company an "outperform" rating in a research note on Wednesday, April 10th. Finally, Morgan Stanley lifted their price objective on MetLife from $80.00 to $82.00 and gave the company an "overweight" rating in a research note on Monday, April 15th. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. According to MarketBeat.com, MetLife presently has a consensus rating of "Moderate Buy" and an average price target of $79.23.

Check Out Our Latest Research Report on MetLife

Insiders Place Their Bets

In other MetLife news, insider Ramy Tadros sold 4,026 shares of the business's stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total transaction of $289,469.40. Following the completion of the transaction, the insider now owns 146,981 shares in the company, valued at approximately $10,567,933.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, EVP Bill Pappas sold 27,000 shares of the company's stock in a transaction on Monday, March 18th. The stock was sold at an average price of $72.27, for a total value of $1,951,290.00. Following the completion of the sale, the executive vice president now owns 57,768 shares in the company, valued at $4,174,893.36. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Ramy Tadros sold 4,026 shares of the company's stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total value of $289,469.40. Following the completion of the sale, the insider now owns 146,981 shares of the company's stock, valued at approximately $10,567,933.90. The disclosure for this sale can be found here. 0.32% of the stock is currently owned by insiders.

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Should you invest $1,000 in MetLife right now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Featured Articles and Offers

Search Headlines: